Loading
Latest filing published 03 Mar 2026 for Lexicon Pharmaceuticals, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Brian T. Crum on record concern Lexicon Pharmaceuticals, Inc., in the capacity of board member. We count 32 filings; the first trade dates from 28 February 2020 and the latest from 28 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 March 2026, the filings show an option exercise in Lexicon Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations